Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Posters

Search Title by author or title

Indication for and results of transcleral sutured secondary implanted intraocular lenses

Poster Details

First Author: A. Paul GERMANY

Co Author(s):    G. Sauder                    

Abstract Details

Purpose:

To assess indication and results IOL explantation and implantation of transscleral sutured IOLs

Setting:

Charlottenklinik eye hospital Retrospective clinical study of IOL explantation and secondary IOL implantation in 2013

Methods:

The indication of 100 referred patients for secondary IOL implantation in 2013 were assessed. After secondary IOL implantation with transscleral fixation, mean outcome measurements were visual acuity, intraocular pressure, surgical complications, and IOL associated astigmatism.

Results:

We retrospectively indentified 4 main reason for secondary IOL implantation: 1. luxation or subluxation in the vitreous cavity in 82%, in all cases more than 5 years after cataract surgery . 2. Aphakia in 10%, either more than 5 years after ICCE or in the first period after complicated cataract surgery. 3. Intra- or perioperatively luxation of phakos or IOL in the vitreous cavity (6%). 4. In 4% the IOL was sutured after complicated vitreoretinal surgery. The postoperative BCVA was 0.6 +/- 0.22, IOP was 16.6 +/- 4.2 mmHg. 3 patients required additional surgery for bad IOL alligment (2) or rupture of the suture (1). The astimgatism after subtraction of the corneal astigmatism, was smaller than 0.75 diopters.

Conclusions:

The wast majority of indication for transscleral fixation of secondary implated IOLs is the luxation of the IOL in weak zonules e.g. in pseudoexfoliatio syndrome, more than 5 years after cataract surgery. In these cases a pars plana vitrectomy was perfomed to get the IOL out of the vitreous. We found the transscleral sutering of the IOL to be a safe and efficient methods with regard to stability and complications.

Financial Disclosure:

NONE

Back to Poster listing